New drugs for hepatitis and diabetes may come from Siberia
26 April 2016
In Siberia, scientists have leveraged years of research into the properties of stem cells in a new project aimed at developing new drugs to fight hepatitis and diabetes.
EuroBiotech Report: MedCity forecasts shortfall in London lab space
26 April 2016
Welcome to the latest edition of our weekly EuroBiotech Report. We start this week in London, where a report from MedCity highlighted the difficulties of trying to fit a growing biotech sector into an already congested city.
States' efforts to fight skyrocketing costs pose 'modest risk to pharma': Report
25 April 2016
States across the country have been battling it out with Big Pharma over drug pricing, with some introducing bills that take aim at skyrocketing costs. People on both sides of the issue are wondering whether the states’ efforts will pay off, and now, some analysts have an answer: “probably not.”
BBA formed to help U.K. catch up on biosimilars scene
25 April 2016
Biosimilars companies have joined forces to drive uptake of their products in the U.K., securing the backing of the National Health Service's (NHS) chief pharmaceutical officer in a push to promote competition against higher-price originators.
Money from home: European biotech turns back to home turf
22 April 2016
Even if the U.S. public markets are cooling on European biotech, a clutch of recent transactions suggests that companies' home markets still remain supportive. Financing activity has been sluggish this year, in contrast with last year, but a trickle of cash is still flowing into European biotech.
Need trial amendments? It'll cost money and time
22 April 2016
A new study in Therapeutic Innovation & Regulatory Science from the Tufts Center for the Study of Drug Development (CSDD) using data from 15 pharmaceutical companies and contract research organizations establishes price tags for the cost of implementing clinical trial amendments
Ask your doc? Consumers are so over pharma TV ads
22 April 2016
What a difference a year has made in the life of pharma TV ads. A second annual patient view study from Treato just out found that the number of consumers who will ask their doctor about a drug after watching a TV ad dropped to just 7% this year, from 21% last year.
Game-playing patients more likely to refill meds: Study
21 April 2016
HealthPrize Technologies has talked up gamification as a way to get patients to stick to their meds. Now, the company is trotting out new data supporting its approach. HealthPrize found that individuals participating in its digital adherence program were more likely to stick to their cholesterol-lowering meds.
An international commitment to fighting antimicrobial resistance
21 April 2016
Medical professionals, businesses and government officials from around the world joined in Amsterdam on the sidelines of the ECCMID 2016 Conference, hosted by ESCMID, to declare their commitment to fight antimicrobial resistance (AMR) in a concerted effort.
What does 'breakthrough' mean to docs and consumers? It's not the FDA definition
20 April 2016
According to the dictionary, the word breakthrough means “a sudden, dramatic and important discovery or development.” However, what many doctors don’t know is that it doesn’t have the same meaning in the FDA drug approval process.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Putin has stated that Russia will support Africa in the struggle against epidemics
19 April 2024
The Russian government has expanded the list of vital and essential drugs
19 April 2024
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024